Insulet (PODD)
146.41
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 INSULET CORP For: Jun 03 Filed by: STONESIFER TIMOTHY C.
June 4, 2026 4:26 PM - SEC Filing
Form 4 INSULET CORP For: Jun 03 Filed by: BORIO LUCIANA
June 4, 2026 4:23 PM - SEC Filing
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sess
June 4, 2026 7:00 AM - BizWire
Form 4 INSULET CORP For: Jun 03 Filed by: WEATHERMAN ELIZABETH H
June 3, 2026 4:19 PM - SEC Filing
Form 144 INSULET CORP Filed by: BORIO LUCIANA
June 3, 2026 3:07 PM - SEC Filing
Insulet rolls out enhanced Omnipod 5 algorithm with Abbott sensor compatibility
June 3, 2026 7:02 AM - StreetInsider
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
June 3, 2026 7:00 AM - BizWire
Form SD INSULET CORP
May 28, 2026 4:50 PM - SEC Filing
Insulet Corporation (PODD) PT Lowered to $165 at Citi
May 28, 2026 6:53 AM - StreetInsider
Insulet to Participate in William Blair 46th Annual Growth Stock Conference
May 27, 2026 4:05 PM - BizWire
Benchmark Reiterates Buy Rating on Insulet Corporation (PODD)
May 27, 2026 9:26 AM - StreetInsider
After-hours movers: ZS, APPS, SMTC, BOX, PODD, VRRM, FLY
May 26, 2026 4:28 PM - StreetInsider
Form 8-K INSULET CORP For: May 26
May 26, 2026 4:15 PM - SEC Filing
Insulet recalls 7 million Omnipod insulin pumps due to leakage risk
May 26, 2026 4:06 PM - StreetInsider
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets
May 26, 2026 4:05 PM - BizWire
Form 4 INSULET CORP For: May 20 Filed by: WEATHERMAN ELIZABETH H
May 21, 2026 4:41 PM - SEC Filing
Form 4 INSULET CORP For: May 20 Filed by: STONESIFER TIMOTHY C.
May 21, 2026 4:39 PM - SEC Filing
Form 4 INSULET CORP For: May 20 Filed by: Scannell Timothy J
May 21, 2026 4:38 PM - SEC Filing
Form 4 INSULET CORP For: May 20 Filed by: MINOGUE MICHAEL R
May 21, 2026 4:36 PM - SEC Filing
Form 4 INSULET CORP For: May 20 Filed by: Huffines Robert Luther
May 21, 2026 4:35 PM - SEC Filing
Form 4 INSULET CORP For: May 20 Filed by: Hopfield Jessica
May 21, 2026 4:33 PM - SEC Filing
Form 4 INSULET CORP For: May 20 Filed by: Frederick Wayne A.I.
May 21, 2026 4:31 PM - SEC Filing
Form 4 INSULET CORP For: May 20 Filed by: BORIO LUCIANA
May 21, 2026 4:29 PM - SEC Filing
Form 8-K INSULET CORP For: May 20
May 21, 2026 4:07 PM - SEC Filing
William Blair Assumes Insulet Corporation (PODD) at Outperform
May 20, 2026 8:35 AM - StreetInsider
Form 4 INSULET CORP For: May 13 Filed by: McEvoy Ashley
May 15, 2026 4:28 PM - SEC Filing
Form SCHEDULE 13G/A INSULET CORP Filed by: Capital Research Global Investors
May 14, 2026 10:20 AM - SEC Filing
Benchmark Reiterates Buy Rating on Insulet Corporation (PODD)
May 11, 2026 4:20 PM - StreetInsider
RBC sees over 80% upside to its price target for this medical stock
May 8, 2026 8:00 PM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $198 at Barclays
May 8, 2026 4:06 AM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $275 at JPMorgan
May 7, 2026 9:27 AM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $255 at Wells Fargo
May 7, 2026 8:23 AM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $250 at Stifel
May 7, 2026 7:31 AM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $250 at Truist Securities, 'Elite Growth Profile Looking More & More Mispriced'
May 7, 2026 7:12 AM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $248 at Baird
May 7, 2026 7:10 AM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $249 at Canaccord
May 7, 2026 6:39 AM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $280 at RBC Capital, 'Best-in-class Financial Profile Intact'
May 7, 2026 6:29 AM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $210 at Oppenheimer
May 7, 2026 6:10 AM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $200 at Bernstein SocGen Group, 'shares fall; what now?'
May 7, 2026 5:04 AM - StreetInsider
Form 10-Q INSULET CORP For: Mar 31
May 6, 2026 4:04 PM - SEC Filing
Insulet Corporation (PODD) PT Lowered to $260 at BTIG
May 6, 2026 1:23 PM - StreetInsider
Form SCHEDULE 13G/A INSULET CORP Filed by: FMR LLC
May 6, 2026 11:24 AM - SEC Filing
Form 8-K INSULET CORP For: May 06
May 6, 2026 7:06 AM - SEC Filing
Insulet (PODD) Tops Q1 EPS by 22c
May 6, 2026 7:05 AM - StreetInsider
Insulet Reports First Quarter 2026 Results
May 6, 2026 7:00 AM - BizWire
Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities
May 5, 2026 7:00 AM - BizWire
Insulet begins pivotal trial for fully closed-loop diabetes system
May 4, 2026 7:02 AM - StreetInsider
Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes
May 4, 2026 7:00 AM - BizWire
Form SCHEDULE 13G INSULET CORP Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 10:43 AM - SEC Filing
Form 8-K INSULET CORP For: Apr 29
April 29, 2026 4:05 PM - SEC Filing
Insulet to Participate in BofA Securities 2026 Health Care Conference
April 28, 2026 7:00 AM - BizWire
Rothschild Redburn Downgrades Insulet Corporation (PODD) to Neutral
April 24, 2026 3:13 AM - StreetInsider
Q1 MedTech quarterly preview: BTIG
April 18, 2026 10:00 PM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $315 at Truist Securities
April 15, 2026 7:15 AM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $320 at BTIG
April 13, 2026 8:16 AM - StreetInsider
Insulet Corporation (PODD) PT Lowered to $277 at Goldman Sachs
April 9, 2026 5:56 AM - StreetInsider
Citi Downgrades Insulet Corporation (PODD) to Neutral
April 7, 2026 6:38 AM - StreetInsider
Form DEFA14A INSULET CORP
April 6, 2026 4:08 PM - SEC Filing
Form DEF 14A INSULET CORP For: May 20
April 6, 2026 4:07 PM - SEC Filing
Insulet Corporation (PODD) PT Lowered to $240 at Evercore ISI
April 6, 2026 8:28 AM - StreetInsider
Form 4 INSULET CORP For: Apr 01 Filed by: Panos Michael
April 2, 2026 4:14 PM - SEC Filing
Form 3 INSULET CORP For: Mar 30 Filed by: Panos Michael
April 2, 2026 4:11 PM - SEC Filing
Form 4 INSULET CORP For: Mar 31 Filed by: Huffines Robert Luther
April 2, 2026 4:09 PM - SEC Filing
Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026
April 1, 2026 7:00 AM - BizWire
Insulet names Mike Panos chief commercial officer
March 30, 2026 8:30 AM - StreetInsider
Insulet Appoints Mike Panos as Chief Commercial Officer
March 30, 2026 8:30 AM - BizWire
Form SCHEDULE 13G/A INSULET CORP Filed by: VANGUARD GROUP INC
March 27, 2026 9:52 AM - SEC Filing
Form 8-K INSULET CORP For: Mar 12
March 12, 2026 4:08 PM - SEC Filing
INSULET recalls specific Omnipod 5 pods due to insulin leak risk
March 12, 2026 4:05 PM - StreetInsider
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.
March 12, 2026 4:05 PM - BizWire
Insulet reports positive results for closed-loop diabetes system
March 11, 2026 4:01 PM - StreetInsider
Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes
March 11, 2026 4:01 PM - BizWire
Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
March 10, 2026 7:00 AM - BizWire
Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'
March 9, 2026 8:18 AM - StreetInsider
Full Article List